Journals / Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi / 2006 / Cilt: 16 - Sayı: 3

Oral lichen planus (4 case report)

Oral liken planus (4 vaka raporu)

Pages
56–60
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially, the atrophic and erosive forms of Oral lichen planus may be painful.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Oral lichen planus is a chronic inflamatory disorder that primarily affects skin and oral cavity.
📊
Key Findings & Data:This disease affects 0.5-2 % of the population and is one of the more common oral mucosal diseases.
💡
Conclusion & Impact:Especially, the atrophic and erosive forms of Oral lichen planus may be painful.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Oral lichen planus is a chronic inflamatory disorder that primarily affects skin and oral cavity. Although the cause of this condition remains unknown the underlying immunopathologic mechanisms that result in the migration of chronic inflamatory cells to the involved dermal and mucosal sites have been well described. Recent data suggest that auto-reactive cyto-toxic T-cells trigger keratinocyte apoptosis in Oral lichen planus. Although Oral lichen planus develops most commonly in the fifth to sixth decades of the life, patients of all ages may develop the disorder . This disease affects 0.5-2 % of the population and is one of the more common oral mucosal diseases. Especially, the atrophic and erosive forms of Oral lichen planus may be painful.

Özet

Oral liken plan us (OLP) başlıca deri ve ağız mukozasını etkileyen kronik enflamatuar bir hastalıktır. Bu durumun nedeni tam olarak açıklanamamış olmasına rağmen, altta yatan immunopatolojik mekanizmalarda, etkilenen deri ve mukozal alanlara kronik enflamatuar hücrelerin migrasyonu iyi tanımlanmıştır. Son veriler OLP'de oto-reaktif sitotoksik T-hücrelerinin keratinosit apopitozisini tetiklediğini düşündürmektedir. OLP en sık hayatın beşinci ve altıncı dekatında ortaya çıkmasına rağmen her yaşta görülebilmektedir. Bu hastalık toplumun %0.5-2'sini etkiler ve en yaygın ağız mukozası hastalıklarından birisidir. Özellikle atrofik ve eroziv formu ağrılı olabilmektedir.

🔖

Cite This Article

MİLOĞLU, Ö., DAĞİSTAN, S., GÖREGEN, M. (2022). Oral lichen planus (4 case report). Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, Cilt: 16 - Sayı: 3, 56–60. https://ajindex.com/articles/452769

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Per -Olof R, Mats J, Magnus H, Ulf B, Göran L Erosive oral lichen planus and salivary cortisol. J Oral Pathol Med 2001; 30: 257-63
  2. Guldo V, Marco P, Marco C, Mario C, Virginio B, Giorgio P, Sergio G. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med 2001; 30:135-40
  3. Martin HT, Micheal NP, Raymond KS, Elizabeth DT. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol 2003; 95(3):291-99
  4. Ambereen K, Camile SF, Neil WS, Laurence JW, Doug JH and Philip BS. Thl cytokines in oral lichen planus.Journal of Oral Pathology and Medicine 2003; 32(2): 77-80
  5. Drore E. Evaluating and treating patients with oral lichen planus. Dermatologic Therapy 2002; 15: 206-17 6. Klanrit P, Thongprasom K, Rojanawatsir S, Theamboonlers A, Poovorawan Y. Hepatitis C virus infection in Thai patients with oral lichen planus. Oral Diseases 2003; 9:292-97 7. Ivanovski K, Nakova Mf Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, Angelov N. Psychological profile in oral lichen planus. J Clin Periodontol 2005; 32:1034-40
  6. Car bone M,.Goss E, Carozzo M, Castellano S, Controtto D, Broccoletti R, Gandolfo S. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. Journal of Oral Patholog and Medicine 2003; 32:323-26
  7. Neville BW, Damm DD,Allen CM, Jerry EB. Oral and Maxillofacial Pathology. 1 ed. W.B. Saunders Company; 1995:572-77 10. Taniguchi Y, Nagao T, Maeda H, Kameyama Y and Warnakulasuriya K.A.A.S. Epithelial cell proliferation in oral lichen planus. Oral Medicine and Pathology. 2002; 35:103-9 11. Zhao Z.Z, Savage N. W, Sugerman P.B, Walsh L.J. Review Article Mast cell/T cell interactions in oral lichen planus. J Oral Pathol Med 2002; 31:180-95 12. Petruzzi M, De Beneditis M, Grassi R, Cassano N, Vena G, Serpico R. Oral lichen planus: a preliminary clinical study on treatment with tazarotene. Oral Diseases 2002; 8:291-95 13. Yiannias JA el-Azhary RA, Hand JH, Pakzad SY, Rogerts RS. Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J am Acad dermatol 2000; 42(21): 177-82
  8. Porter SR. Oral lichen planus and choronic liver disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 79; 267-68
  9. Potts A3, Hamburger J, Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory